Techniques for irreversible electroporation using a single-pole tine-style internal device communicating with an external surface electrode
Techniques for High-Frequency Irreversible Electroporation (HFIRE) using a single-pole tine-style internal device communicating with an external surface electrode are described. In an embodiment, a system for ablating tissue cells in a treatment region of a patient's body by irreversible electroporation without thermally damaging the tissue cells is described. The system includes at least one single-pole electrode probe for insertion into the treatment region, the single-pole electrode probe including one or more tines. The system further includes at least one external surface electrode for placement outside the patient's body and configured to complete a circuit with the single-pole electrode probe. The system also includes a control device for controlling HFIRE pulses to the single-pole tine-style electrode and the skin-surface electrode for the delivery of electric energy to the treatment region. Other embodiments are described and claimed.
1. A method for ablating cells in a treatment site of a patient comprising:
placing a probe into the treatment site, the probe comprising a probe electrode;
placing a surface electrode on a first location of a surface of an organ of the patient;
activating a generator, the generator to be operatively coupled to the probe and to the surface electrode, the generator generates a first set of electrical pulses between the probe electrode and the surface electrode at the first location, the first set of electrical pulses sufficient to: (i) create an initial ablation zone; and (ii) induce a first electrical pull zone such that a size of the initial ablation zone is increased, wherein the first set of electrical pulses is sufficient to ablate cells in the treatment site by irreversible electroporation; and
moving the surface electrode to a second location on the surface of the organ of the patient; and
activating the generator to generate a second set of electrical pulses between the probe electrode and the surface electrode at the second location sufficient to induce a second electrical pull zone.
2. The method of claim 1 , wherein the first set of electrical pulses and the second set of electrical pulses are insufficient to thermally damage tissue within the treatment site.
3. The method of claim 1 , wherein the first set of electrical pulses and the second set of electrical pulses are insufficient to induce muscle contractions in the patient.
4. The method of claim 1 , wherein the initial ablation zone and the first pull zone combine to form a substantially non-spherical ablation shape.
5. The method of claim 1 , further comprising the steps of:
moving the surface electrode to a third location on the surface of the organ of the patient;
activating the generator to generate a third set of electrical pulses between the probe electrode and the surface electrode at the third location sufficient to induce a third electrical pull zone;
moving the surface electrode to a fourth location on the surface of the organ of the patient; and
activating the generator to generator a fourth set of electrical pulses between the probe electrode and the surface electrode at the fourth location sufficient to induce a fourth electrical pull zone.
6. The method of claim 5 , wherein the second electrical pull zone is sufficient to increase the size of the initial ablation zone; third electrical pull zone is sufficient to increase the size of the initial ablation zone; and the fourth electrical pull zone is sufficient to increase the size of the initial ablation zone.
7. The method of claim 1 , wherein the organ is skin.
8. The method of claim 1 , wherein the first set of electrical pulses comprise a bi-phasic waveform; a pulse width of between 100 nanoseconds and 10 microseconds; the first set of electrical pulses delivered in burst widths of 500 nanoseconds to 1 millisecond; and a time delay between the bursts is between 1 millisecond and 5 seconds.
9. The method of claim 1 , wherein the probe comprises a single-pole tine style electrode probe.
10. The method of claim 1 , further comprising the step of:
monitoring an impedance of the initial ablation zone.
11. The method of claim 1 , wherein the probe electrode comprises a monopolar electrode.
12. A method for ablating target tissue in a treatment site comprising:
placing a probe into the treatment site, the probe comprising a probe electrode;
placing a surface electrode on a first location of a surface of a patient;
activating a generator, the generator to be operatively coupled to the probe and to the surface electrode, the generator generates a first set of bi-phasic electrical pulses between the probe electrode and the surface electrode at the first location, the first set of bi-phasic electrical pulses sufficient to: (i) create an initial substantially spherical ablation zone; (ii) induce a first electrical pull zone such that the substantially spherical initial ablation zone is increased in size; and (iii) sufficiently ablate the target tissue in the treatment site, wherein the first set of bi-phasic electrical pulses are sufficient to non-thermally irreversibly electroporate the target tissue;
moving the surface electrode to a second location on the surface of the patient; and
activating the generator to generate a second set of electrical pulses between the probe electrode and the surface electrode at the second location sufficient to induce a second electrical pull zone.
13. The method of claim 12 , wherein the second set of electrical pulses comprise a bi-phasic waveform.
14. The method of claim 12 , wherein the first set of electrical pulses and the second set of electrical pulses are insufficient to create muscle contractions in the patient.
15. The method of claim 12 , wherein the probe further comprises at least one deployable tine electrode.
16. A method for ablating cells in a treatment site of a patient comprising:
placing a probe into the treatment site, the probe comprising a probe electrode;
placing a surface electrode on a first location of a surface of an organ of the patient;
activating a generator, the generator to be operatively coupled to the probe and to the surface electrode, the generator generates a first set of bi-phasic electrical pulses between the probe electrode and the surface electrode at the first location, the first set of bi-phasic electrical pulses sufficient to: (i) create an initial ablation zone; (ii) induce a first electrical pull zone such that the initial ablation zone is increased up to 3 millimeters, wherein the first set of bi-phasic electrical pulses are sufficient to non-thermally irreversibly electroporate cells in the treatment site;
moving the surface electrode to a second location on the surface of the organ of the patient;
activating the generator to generate a second set of bi-phasic electrical pulses between the probe electrode and the surface electrode at the second location sufficient to induce a second electrical pull zone.
17. The method of claim 16 , further comprising the steps of:
moving the surface electrode to a third location on the surface of the organ of the patient; and
activating the generator to generate a third set of bi-phasic electrical pulses between the probe electrode and the surface electrode at the third location sufficient to induce a third electrical pull zone.
18. The method of claim 17 , further comprising the steps of:
moving the surface electrode to a fourth location on the surface of the organ of the patient; and
activating the generator to generate a fourth set of bi-phasic electrical pulses between the probe electrode and the surface electrode at the fourth location sufficient to induce a fourth electrical pull zone.
19. The method of claim 16 , wherein the probe further comprises a deployable tine electrode, and the method further comprises the step of:
deploying the deployable tine electrode.
20. The method of claim 16 , wherein the first set of bi-phasic electrical pulses are generated in a pattern which has been predetermined to maintain a temperature of the treatment site below 70 degrees C.